Quick Takeaways
- SUVRETTA CAPITAL MANAGEMENT, LLC filed SCHEDULE 13G/A for Aura Biosciences, Inc. Common Stock, par value $0.00001 per share (AURA).
- Disclosed ownership: 7.6%.
- Date of event: 30 Jun 2025.
SUVRETTA CAPITAL MANAGEMENT, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Aura Biosciences, Inc. Common Stock, par value $0.00001 per share (AURA)
- Filing Manager
- SUVRETTA CAPITAL MANAGEMENT, LLC
- Reporting Manager
- Suvretta Capital Management, LLC
- Symbol
- AURA
- Shares outstanding
- 61,865,461 shares
- Disclosed Ownership
- 4,701,775 shares
- Ownership
- 7.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Aug 2025, 20:01:00 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 11 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"SUVRETTA CAPITAL MANAGEMENT, LLC disclosed 7.6% ownership in Aura Biosciences, Inc. Common Stock, par value $0.00001 per share (AURA) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 11 Apr 2025.
- Current filing was accepted on 13 Aug 2025, 20:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 7.6% | 4,701,775 | 0 | 4,701,775 | /s/ Andrew Nathanson | Andrew Nathanson/General Counsel and Chief Compliance Officer | |
| Averill Master Fund, Ltd. | 6.6% | 4,137,797 | 0 | 4,137,797 | /s/ Andrew Nathanson | Andrew Nathanson/Authorized Signatory | |
| Aaron Cowen | 7.6% | 4,701,775 | 0 | 4,701,775 | /s/ Aaron Cowen | Aaron Cowen |